Atlas Clinical Research
Matthew Stober is an accomplished executive in the biopharmaceutical and medical technology sectors, currently serving as Chief Executive Officer of Abzena since January 2023. Stober holds multiple board member positions, including roles at Atlas Clinical Research, Leiters Health, Istari Oncology, and CastleVax, along with past involvement as a board member at X-Vax Technology, Inc., and Bioventus. Previous senior leadership experience includes serving as Chief Operating Officer at Vyaire Medical and President of Global Operations at Smith & Nephew. Stober's education includes two degrees in Chemical Engineering from Villanova University, enhancing a robust career dedicated to driving innovation and operational excellence in healthcare.
This person is not in any teams
Atlas Clinical Research
Atlas Clinical Research is a therapeutically-focused network of sites that aims to drive the success of clinical trials. By delivering vital data to our sponsors, Atlas successfully facilitates the speed to market of products while simultaneously ushering patients toward ground-breaking medical treatments. Over the past 30 years, sponsors and CROs have come to view the individual investigator sites within Atlas’s portfolio as centers of excellence for the study of internal medicine, central nervous system, gastrointestinal medicine and infectious disease. Atlas aligns our interests with our sponsors, consistently putting patients at the center of everything we do. By creating an environment where employees and member sites can thrive, Atlas streamlines innovative solutions that excel processes and resources, which can be leveraged across the entire network. Through Atlas, investigators, care teams, and member sites can focus on what truly matters: quality data and outstanding patient care.